Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
123.77
+6.49 (5.53%)
At close: Jun 26, 2026, 4:00 PM EDT
122.44
-1.33 (-1.07%)
After-hours: Jun 26, 2026, 6:13 PM EDT
Mirum Pharmaceuticals Employees
Mirum Pharmaceuticals had 418 employees as of March 31, 2026. The number of employees increased by 46 or 12.37% since the number was last reported on December 31, 2025.
Employees
418
Change
46
Growth
12.37%
Revenue / Employee
$1,362,701
Profits / Employee
-$1,911,103
Market Cap
7.55B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Vaxcyte | 507 |
| Rhythm Pharmaceuticals | 414 |
| TG Therapeutics | 399 |
| Immunovant | 315 |
| Scholar Rock Holding | 289 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
MIRM News
- 1 day ago - Biotech ETF Index Surges 10% After Rebalance - ETF Trends
- 11 days ago - Mirum Pharmaceuticals price target raised to $146 from $140 at Citizens - TheFly
- 12 days ago - Incyte, Mirum announces Phase 2 results from Cohort 1 of Progress study - TheFly
- 12 days ago - Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva - Business Wire
- 13 days ago - Mirum Pharmaceuticals Slides: Study update presentation - Filings
- 15 days ago - Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 15 days ago - Mirum Pharmaceuticals price target raised to $150 from $140 at Morgan Stanley - TheFly
- 22 days ago - Incyte, Mirum to present Phase 2 results from PROGRESS study at ENDO 2026 - TheFly